New rifamycins produced by a recombinant strain of Nocardia mediterranei.
- 1 January 1981
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 34 (8) , 965-970
- https://doi.org/10.7164/antibiotics.34.965
Abstract
A recombinant strain of N. mediterranei produces a number of new rifamycins which are structurally related to rifamycin S, rifamycin W and rifamycin G. This strain was derived from 2 N. mediterranei mutants by intraspecific recombination.This publication has 4 references indexed in Scilit:
- 3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterranei.The Journal of Antibiotics, 1981
- Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-type.The Journal of Antibiotics, 1980
- Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proasamycin B-M1 and protorifamycin I-M1.The Journal of Antibiotics, 1979
- Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I.The Journal of Antibiotics, 1978